PRESBYTERIAN HOSPITAL HUNTERSVILLE
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $11.3M
- Transactions
- 1,059
- Companies
- 40
- Average per transaction
- $10,709
Who reported the payments
| Astrazeneca UK Limited | $2,316,393 |
| Acerta Pharma LLC | $1,656,605 |
| Hoffmann-la Roche Limited | $914,972 |
| Bristol Myers Squibb | $876,364 |
| Merck | $873,975 |
| Boston Scientific | $496,146 |
| Genentech, Inc. | $456,271 |
| Edwards Lifesciences | $451,727 |
| Abbott | $410,863 |
| Amgen | $382,923 |
| Janssen Research & Development, LLC | $372,685 |
| Eli Lilly | $347,549 |
| Novartis | $321,636 |
| AstraZeneca | $218,414 |
| Kowa Research Institute, Inc. | $182,537 |
| Sanofi US Services Inc. | $163,410 |
| AbbVie | $154,078 |
| F. Hoffmann-la Roche AG | $107,601 |
| Esperion Therapeutics, Inc. | $91,487 |
| Insulet Corporation | $73,400 |
| Terumo Medical Corporation | $60,941 |
| Novo Nordisk AS | $42,511 |
| ADC Therapeutics America, Inc. | $39,736 |
| CSL Behring | $35,135 |
| Sanofi | $34,900 |
| Iovance Biotherapeutics, Inc. | $27,979 |
| ZOLL Respicardia, Inc. | $20,898 |
| National Marrow Donor Program | $19,645 |
| Celularity Inc. | $16,735 |
| Vifor (international) Ltd. | $16,550 |
| Medtronic | $16,000 |
| Secura Bio, Inc. | $15,959 |
| Novocure GmbH | $14,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13,702 |
| Viz.ai, Inc. | $13,500 |
| Verastem, Inc. | $12,480 |
| Pharmacyclics LLC, An Abbvie Company | $7,525 |
| Bard Peripheral Vascular, Inc. | $5,940 |
| United Therapeutics Corporation | $5,790 |
| Johnson & Johnson | $5,000 |